• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Interview

Dr. Tod C. Engelhardt, Discusses Catheter-Directed, Ultrasound-Accelerated Thrombolysis to Treat Pulmonary Embolism

  • Fri, 1/6/12 - 2:58pm
  • 0 Comments
  • 2918 reads

Tell me about your recently published study regarding the use of catheter-directed ultrasound-accelerated thrombolysis for the treatment of pulmonary embolism.

This is a really exciting new thing for me, and actually a new thing for the world for that matter, in the treatment of pulmonary embolism. Pulmonary embolism can be and frequently is a life-threatening condition and we’re taking patients now with a significant clot burden, a significant degree of debility from pulmonary embolism, and treating them with ultrasound-assisted thrombolysis, which means that we are using a drug to dissolve blood clots in combination with ultrasound technology.



Read the full story >>

Q&A with Dr. Michael Werk, of Martin Luther Hospital, About Femoropopliteal Lesions and the PACIFIER Trial

  • Fri, 1/6/12 - 2:46pm
  • 0 Comments
  • 389 reads

Tell me about the recent Paclitaxel-coated Balloons in Femoral Indication to Defeat Restenosis (PACIFIER) Trial and its significance for patients with femoropopliteal lesions.

The PACIFIER Trial evaluated prevention of restenosis with paclitaxel-coated PTA balloon catheters in stenosis or occlusion of femoropopliteal arteries versus a control group treated with uncoated balloons. We specifically looked at the In.Pact Pacific drug-eluting balloon (Medtronic).



Read the full story >>

Q&A with Dr. R. Clement Darling About the Find the AAAnswers Campaign and Abdominal Aortic Aneurysm Awareness

  • Fri, 12/2/11 - 4:54pm
  • 0 Comments
  • 697 reads

Tell me about the Find the AAAnswers campaign and how it began.

There are about 1 and a half million people in the United States who have an undiagnosed problem called an abdominal aortic aneurysm. If they are under- or undiagnosed during the patient’s lifetime, there is a significant chance that they may rupture, and if they rupture, about 90% of the patients die.



Read the full story >>

Q&A with Dr. Lowell S. Kabnick, MD, About the New VenaCure 1470 nm Laser for the Treatment of Varicose Veins

  • Tue, 11/1/11 - 1:53pm
  • 0 Comments
  • 1146 reads

Tell me about the latest advances in endovascular laser therapy for varicose veins.

There have been 2 major advances in endovascular laser therapy for varicose veins. First is the advent of lasers using 1470 nm and other water-specific wavelengths. Second is the use of jacket-tip laser fibers.



Read the full story >>

Dr. David W. Newell Speaks with VDM About the First Successful Use of Ultrasound Technology to Treat Hemorrhagic Stroke Within the Brain

  • Wed, 10/5/11 - 10:19am
  • 1 Comments
  • 827 reads

Your recently published article in the Journal of Neurosurgery describes a new study that made you the first to report successful use of ultrasound technology to treat hemorrhagic stroke. How did the study get started?

The study got started due to the fact that a company in the Seattle area called EKOS had an exciting new technology involving ultrasound for breaking up blood clots and they designed a number of catheters for breaking up blood clots in different areas of the body.



Read the full story >>

Stem Cell Research for Treatment of Critical Limb Ischemia with Dr. Michael R. Go, Ohio State University Medical Center

  • Wed, 9/7/11 - 11:09am
  • 0 Comments
  • 1344 reads

How prevalent is critical limb ischemia now?

Critical limb ischemia is, unfortunately, quite prevalent. There are about 1,000 cases of critical limb ischemia per 1 million in the U.S. population. That’s somewhere between 50,000 and 75,000 patients a year that are affected.



Read the full story >>

Endovascular Repair Q&A with Dr. Thomas Maldonado, New York University Langone Medical Center

  • Wed, 8/3/11 - 10:42am
  • 0 Comments
  • 1610 reads

Tell me about the latest advances in endovascular aneurysm repair.

It’s hard to believe that this technology has been around for more than 20 years now. What’s equally amazing is that while there have been tremendous changes and advances in the technology, much of the pitfalls and challenges identified and predicted by Dr. Parodi and his colleagues in Argentina in 1991 persist today.



Read the full story >>

Vascular Practice Development Q&A with Gary M. Ansel, MD

  • Thu, 6/2/11 - 3:41pm
  • 0 Comments
  • 1307 reads

How can vascular interventionists expand their practice in today’s market?
Today’s market will be expanded by the increase in outcome data being generated. The 2 major trials that I predict will increase the market are the CREST data that show similar outcomes to caroti­­­d endarterectomy overall while simultaneously demonstrating a tremendous decrease in stroke related to carotid stenting during the last 3 years of the trial. The second major trial success is the Zilver PTX (Cook Medical, Bloomington, Indiana) trial that is demonstrating low restenosis rates utilizing drug-coated stents out to 2 years.



Read the full story >>

VDM speaks with Marco G. Manzi, MD, Chief of the Interventional Radiology Unit in Policlinico Abano Terme (Vincenza, Italy), who presented on “Saving the Limb in Diabetics with Disease of the Leg or Foot” at the 37th Annual VEITHSymposium

  • Tue, 5/3/11 - 3:44pm
  • 0 Comments
  • 845 reads

Tell us where things stand presently with treatment options for diabetics with critical limb ischemia (CLI).
The majority of diabetics with CLI have foot wounds which are very often complicated with infection. The target in these patients is to avoid major amputations (limb salvage). TASC II indicates revascularization as the first-choice treatment for CLI (recommendation no. 24). We know from direct experience and from the literature that endovascular treatment is actually considered the first choice and that this treatment should be part of a multidisciplinary approach.



Read the full story >>

Vascular Practice Development Q&A with James F. Benenati, MD

  • Tue, 5/3/11 - 3:06pm
  • 0 Comments
  • 1317 reads

How can vascular interventionists expand their practice in today’s market?
Peripheral arterial disease (PAD) is still not well recognized in the community and not well understood by many primary care physicians. There is a huge untapped market and many of these patients need help. With physician education and marketing, it is possible to build a reasonable practice. Developing relationships with primary care physicians is critical.



Read the full story >>
  • 1
  • 2
  • 3
  • 4
  • next ›
  • last »

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

The SFA School of Thought Continues

Lawrence A. Garcia MD
more »

Vascular Newswire

  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
  • AMA: Halt Implementation of ICD-10
    Thu, 02/02/12 - 11:56am
  • NHS Makes GBP200 Non-Drug Hypertension Treatment Device Available on Prescription
    Wed, 02/01/12 - 11:06am
  • AngioDynamics to Acquire Navilyst Medical
    Tue, 01/31/12 - 2:48pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

Do you think that endostaples will soon become important tools in the hands of aortic interventionists?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications